Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
J
Jenburkt Pharmaceuticals Ltd
Score 68/100• Decent
Jenburkt Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health84/100
Valuation 60/100 · PB 2.7994
Technical Avoid
1M -16.667% 6M -14.973% 1Y -17.773%
Confidence100%
Low leverage (D/E)No promoter pledge
#46
View details ➜
T
Trident Lifeline Ltd
Score 68/100• Decent
Trident Lifeline Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health70/100
Valuation 20/100 · PB 5.0385
Technical Avoid
1M -6.25% 6M 13.336% 1Y 8.637%
Confidence100%
Healthy profit marginsDecent revenue growth
Promoter pledge present
#47
View details ➜
T
Themis Medicare Ltd
Score 68/100• Decent
Themis Medicare Ltd shows potential but faces several challenges that could impact future performance.
Company’s Health73/100
Valuation 60/100 · PB 2.3629
Technical Avoid
1M -13.876% 6M -28.524% 1Y -63.967%
Confidence100%
Low leverage (D/E)Reasonable PB valuation
Weak ROEPromoter pledge present
#48
View details ➜
T
Tatva Chintan Pharma Chem Ltd
Score 68/100• Decent
Tatva Chintan Pharma Chem Ltd shows potential for growth in a favorable sector, but valuation concerns and execution risks should be monitored.
Company’s Health72/100
Valuation 40/100 · PB 4.5516
Technical Avoid
1M 0.122% 6M 55.206% 1Y 59.194%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#49
View details ➜
S
Suven Life Sciences Ltd
Score 68/100• Decent
Suven Life Sciences Ltd shows potential for growth, but faces challenges in valuation and execution risks.
Company’s Health49/100
Valuation 20/100 · PB 35.3217
Technical Avoid
1M -7.723% 6M -34.455% 1Y 14.995%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#50
View details ➜
S
Solara Active Pharma Sciences Ltd
Score 68/100• Decent
Solara Active Pharma Sciences Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health24/100
Valuation 60/100 · PB 2.395
Technical Avoid
1M 9.829% 6M 16.023% 1Y -20.855%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#51
View details ➜
S
SMS Pharmaceuticals Ltd
Score 68/100• Decent
SMS Pharmaceuticals Ltd shows decent potential with consistent growth, but faces challenges in valuation and liquidity.
Company’s Health66/100
Valuation 40/100 · PB 4.6954
Technical Momentum
1M 8.835% 6M 25.298% 1Y 27.769%
Confidence100%
Low leverage (D/E)
Weak ROEPromoter pledge present
#52
View details ➜
S
Shukra Pharmaceuticals Ltd
Score 68/100• Decent
Shukra Pharmaceuticals Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health89/100
Valuation 20/100 · PB 35.6491
Technical Momentum
1M 16.734% 6M 243.125% 1Y 670.482%
Confidence100%
Low leverage (D/E)No promoter pledge
#53
View details ➜
S
Shelter Pharma Ltd
Score 68/100• Decent
Shelter Pharma Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
Company’s Health84/100
Valuation 80/100 · PB 1.3767
Technical Avoid
1M -17.127% 6M -12.703% 1Y -33.549%
Confidence100%
Low leverage (D/E)No promoter pledge
#54
View details ➜
S
Shanmuga Hospital Ltd
Score 68/100• Decent
Shanmuga Hospital Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health93/100
Valuation 80/100 · PB 1.6775
Technical Momentum
1M 25.195% 6M 29.605% 1Y -3.996%
Confidence100%
Low leverage (D/E)No promoter pledge
#55
View details ➜
S
Shalby Ltd
Score 68/100• Decent
Shalby Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health75/100
Valuation 60/100 · PB 2.0859
Technical Avoid
1M -13.87% 6M 6.447% 1Y -20.121%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#56
View details ➜
S
Samrat Pharmachem Ltd
Score 68/100• Decent
Samrat Pharmachem Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health75/100
Valuation 80/100 · PB 1.1098
Technical Avoid
1M -9.635% 6M -24.168% 1Y -37.425%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#57
View details ➜
R
Rainbow Children's Medicare Ltd
Score 68/100• Decent
Rainbow Children's Medicare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health92/100
Valuation 20/100 · PB 9.5348
Technical Avoid
1M 1.337% 6M -5.034% 1Y -14.946%
Confidence100%
No promoter pledgeHealthy profit margins
#58
View details ➜
P
Panacea Biotec Ltd
Score 68/100• Decent
Panacea Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health55/100
Valuation 60/100 · PB 2.6556
Technical Avoid
1M -16.873% 6M -20.156% 1Y -21.957%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#59
View details ➜
M
Mankind Pharma Ltd
Score 68/100• Decent
Mankind Pharma Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health97/100
Valuation 20/100 · PB 6.1739
Technical Avoid
1M -1.839% 6M -8.837% 1Y -17.795%
Confidence100%
No promoter pledgeHealthy profit margins
#60
View details ➜
Showing 46 to 60 of 301 (21 Pages)